AKT1 and breast carcinoma: We previously highlighted that the melatonin analogue UCM 1037, as well, can trigger and/or inhibit Akt phosphorylation differently in the cell lines examined: p-Akt increased in melanoma DX-3 cells, remained unaffected in melanoma WM-115 cells and dramatically decreased in breast cancer cell lines [17].